期刊文献+

哺乳动物雷帕霉素靶蛋白及其底物激酶在肾癌中的表达及临床意义

Expression of mammalian mTOR and P70S6K in renal cell carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨雷帕霉素靶蛋白(mTOR)和底物激酶(P70S6K)蛋白在肾癌组织中的表达,分析其在肾癌发展中的意义。方法以40例肾癌组织标本、40例正常肾组织标本为对象,行免疫组化SP及Westernblotting法测定组织中mTOR、P70S6K含量,分析其表达与肾癌临床病理参数关系。结果mTOR、P70S6K蛋白在肾癌组织中均呈高表达,正常肾组织呈低表达,对比差异有统计学意义(P〈0.05)。两者在肾癌组织表达与细胞分化程度、淋巴结转移等显著相关(P〈0.05),与年龄、性别无显著相关(P〉0.05)。两者在肾组织中的表达呈正相关(P〈0.05)。结论mTOR、P70S6K在肾癌组织中呈阳性高表达,与细胞分化、淋巴转移等相关。 Objective To explore the expression of mTOR and P70S6K in kidney cancer tissue and analyze its significance in the development of renal cancer. Methods 40 renal carcinoma tissue specimens and 40 normal renal tissue specimens were set as study objects. Immunohistochemical SP and Western blotting method were used to detect the content of mTOR and P70S6K in the tissue.The relationship between expression and kidney cancer clinical pathological parameters was analyzed. Results mTOR and P70S6K more highly expressed in kidney cancer tissue than in normal renal tissue, with statistical differences (P 〈 0.05). The expressions of mTOR and P70S6K in kidney cancer tissue closely correlated with the degree of cell differentiation and lymph node metastasis (P 〈 0.05), but not with age and sex (P 〉 0.05). The expression of mTOR positively correlated with the expression of P70S6K in renal tissue (P 〈0.05). Conclusions The expressions ofmTOR and P70S6K are positively high and correlate with cell differentiation, lymph node metastasis, etc.
出处 《国际医药卫生导报》 2015年第13期1781-1783,共3页 International Medicine and Health Guidance News
基金 沈阳医学院科技基金项目(20121014)
关键词 肾癌 MTOR P70S6K 细胞分子学 Kidney cancer MTOR P70S6K Cell molecular
  • 相关文献

参考文献5

二级参考文献176

  • 1陈庆永,王春友,吴河水,陈道达.外源性PTEN基因诱导人乳腺癌MDA468细胞凋亡[J].中华医学杂志,2005,85(1):33-36. 被引量:12
  • 2Sugatani T,Hruska KA.Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival,respectively,whereas Akt is dispensable for cell survival in isolated osteoclast precursors.J Biol Chem,2005,280(5):3583-3589.
  • 3Inoki K,Li Y,Zhu T,et al.TSC2 is phosphorylated and inhibited by Akt and suppresses Mtor signalling Nat Cell Biol,2002,4(9):648-657.
  • 4Amin RM,Hiroshima K,Miyagi Y,et al.Role of the pI3K/Akt,mTOR,and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung.Pathol Int,2008,58(1):38-44.
  • 5Kunz J, Henriquez R, Schneider U, et al. Target of rapamycinin yeast, TOR2, is an essential phosphatidylinositol kinasehomolog required for G1 progression. Cell, 1993,73 (3):585 -596.
  • 6Huang S, Houghton PJ. Targeting mTOR signaling for cancertherapy. Curr Opin Pharmacol, 2003,3(4):371-377.
  • 7Shamji AF, Nghiem P, Schreiber SL. Integration of growthfactor and nutrient signaling: implications for cancer biology.Mol Cell, 2003,12(2):271-280.
  • 8Seeliger H, Guba M, Kleespies A, et al. Role of mTOR in solidtumor systems: a therapeutical target against primary tumorgrowth, metastases, and angiogenesis. Cancer Metastasis Rev,2007,26(3-4):611-621.
  • 9Chakraborty S, Mohiyuddin SM, Gopinath KS, et al.Involvement of TSC genes and differential expression of othermembers of the mTOR signaling pathway in oral squamous cellcarcinoma. BMC Cancer, 2008,8:163.
  • 10Darb-Esfahani S, Faggad A, Noske A, et al. Phospho-mTORand phospho-4EBP1 in endometrial adenocarcinoma:association with stage and grade in vivo and link with responseto rapamycin treatment in vitro. J Cancer Res Clin Oncol,2009,135(7):933-941.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部